Drug Trials Drugs Life Science 
XTalks
AUGUST 3, 2022
The drug is the first FDA approved oral suspension form of zonisamide. Hear about how the drug could help increase accessibility and flexibility for epilepsy patients and improve treatment adherence. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
pharmaphorum
DECEMBER 1, 2022
To ease this burden, the life sciences industry has been searching for ways to make clinical trials more accessible for patients and to drive participation numbers, increase participant diversity, and improve overall patient experience. Build a base in the community. Keep it simple. In fact, the opposite is true.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Velocity Clinical Research
OCTOBER 21, 2024
For a clinical trials organization to achieve this level of scale is notable. The clinical trials sector in the US is typically made up of small independent businesses that collectively play an important role in trialing new protocols and aiding drug development. Velocity is among the few exceptions.
XTalks
SEPTEMBER 11, 2020
Disease doesn’t discriminate, and researchers understand different populations react differently to drugs. Why, then, are clinical trials so stubbornly homogeneous? Clinical trials, however, don’t reflect that diversity. Why aren’t clinical trials more inclusive? Nearly all diseases have a genetic component.
Advarra
AUGUST 16, 2022
Orphan drugs have historically faced a number of barriers, such as limited research and development (R&D) investment due to an expected lack of profitability as well as challenges in clinical trial design and recruitment. Before 1983, only 38 orphan drugs had received U.S. Food and Drug Administration (FDA) approval.
XTalks
MAY 16, 2023
They aim to improve patient outcomes, slow disease progression and enhance quality of life. Here’s an overview of clinical trials for pulmonary fibrosis: Drug trials: These trials may involve investigational drugs targeting specific pathways involved in fibrosis or assessing the efficacy of approved drugs in combination therapy.
XTalks
APRIL 26, 2021
Related: After 18 Years, FDA Approves Malaria Prevention Drug. Given the success of Oxford’s Phase II trial, the study investigators are now gearing up for a Phase III licensure trial to assess large-scale safety and efficacy in 4,800 children aged 5 to 36 months across four countries in Africa.
Expert insights. Personalized for you.
52 
Let's personalize your content